Abstract:Imbalance of A beta production and A beta removal leads to A beta accumulation. A beta degrading enzyme (including neprilysin-NEP, endothelin converting enzyme-ECE) as a therapeutic strategy for lowering brain A beta deposition has attracted increasing attention. In this study, we investigated alteration of age and region-dependent in APP/PS1 double transgenic mice (3, 6, 9, 12 months) and their age-matched wild type mice including the ability of spatial memory, A beta deposits, the protein expression, location and activity of NEP and ECE. Our data demonstrated that, as compared with wild type mice, APP/PS1 mice displayed significant cognitive deficit at 9 month revealed by obviously longer in the latency and distance to find the platform and shorter in time spent and swimming distance in the target quadrant. A beta(40) and A beta(42) levels exhibited a significant increase with age in the cerebral cortex and hippocampus of APP/PS1 mice after 6 month, compared with their age-matched wild type mice. And A beta(42) levels were significantly higher than A beta(40) levels in the same age of APP/PS1 mice. Furthermore, NEP protein and activity displayed a marked decrease with age in the cerebral cortex and hippocampus of APP/PS1 mice older than 6 month. Slightly different from NEP, ECE protein was up-regulated with age, while ECE activity showed a significantly decrease with age in cortex and hippocampus of APP/PS1 mice older than 6 month. Double immunofluorescence staining also demonstrated that ECE and NEP highly colocalized in cytoplasmic and membrane, and ECE immunoreactivity tended to increase with age in APP/PS1 mice, especially 12 month APP/PS1 mice. Correlation analysis showed the negative correlation between enzyme (NEP or ECE) activity and A beta levels in the cerebral cortex and hippocampus of APP/PS1 mice, which was correlated with A beta accumulation. These results indicate NEP rather than ECE plays more important role in resisting A beta accumulation. The compensatory upregulation of NEP and ECE could balance A beta metabolism and protect neuronal functions in infant and juvenile mice. These evidence might provide some clues for the treatment of Alzheimer's disease.

Overexpression of Neprilysin Reduces Alzheimer Amyloid-Beta42 (Abeta42)-Induced Neuron Loss and Intraneuronal Abeta42 Deposits but Causes a Reduction in Camp-Responsive Element-Binding Protein-Mediated Transcription, Age-Dependent Axon Pathology, and Premature Death in Drosophila.

P1-028: Overexpression of neprilysin reduces Abeta42-induced neuron loss and intraneuronal Abeta42 deposits, but causes age-dependent axon pathology in drosophila

Neprilysin: an Enzyme Candidate to Slow the Progression of Alzheimer'S Disease

Neprilysin Protects Neurons Against Aβ Peptide Toxicity

Dynamic Alteration of Neprilysin and Endothelin-Converting Enzyme in Age-Dependent Appswe/Ps1de9 Mouse Model of Alzheimer'S Disease

Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe/PS1dE9 mouse model of Alzheimer's disease.

P2-296: Enhanced Proteolysis of Aβ Peptide Reduces Tau Phosphorylation and Neurofibrillary Tangle Formation in APP/tau Transgenic Mice

Expression and Functional Profiling of Neprilysin, Insulin‐degrading Enzyme, and Endothelin‐converting Enzyme in Prospectively Studied Elderly and Alzheimer’s Brain

Estrogen Regulation of the Neprilysin Gene Through A Hormone-Responsive Element

Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons.

Effects of HNE‐modification Induced by Aβ on Neprilysin Expression and Activity in SH‐SY5Y Cells

Expression of Neprilysin in Skeletal Muscle by Ultrasound-Mediated Gene Transfer (Sonoporation) Reduces Amyloid Burden for AD.

Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model.

Lipophorin Receptors Genetically Modulate Neurodegeneration Caused by Reduction of Psn Expression in the Aging Drosophila Brain

Neprilysin Confers Genetic Susceptibility to Alzheimer’s Disease in Han Chinese

Levels of Amyloid Beta (Aβ) Expression in the Caenorhabditis elegans Neurons Influence the Onset and Severity of Neuronally Mediated Phenotypes

Intraneuronal Accumulation of Aβ42 Induces Age-Dependent Slowing of Neuronal Transmission in Drosophila

Estrogen Stimulates Degradation of Beta-Amyloid Peptide by Up-Regulating Neprilysin

Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective

Targeting lncRNA NEAT1 Hampers Alzheimer's Disease Progression